817 related articles for article (PubMed ID: 28607171)
21. Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease.
Paula-Lima AC; Brito-Moreira J; Ferreira ST
J Neurochem; 2013 Jul; 126(2):191-202. PubMed ID: 23668663
[TBL] [Abstract][Full Text] [Related]
22. Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers.
Jürgensen S; Antonio LL; Mussi GE; Brito-Moreira J; Bomfim TR; De Felice FG; Garrido-Sanabria ER; Cavalheiro ÉA; Ferreira ST
J Biol Chem; 2011 Feb; 286(5):3270-6. PubMed ID: 21115476
[TBL] [Abstract][Full Text] [Related]
23. Reactive oxygen species released from astrocytes treated with amyloid beta oligomers elicit neuronal calcium signals that decrease phospho-Ser727-STAT3 nuclear content.
Muñoz Y; Paula-Lima AC; Núñez MT
Free Radic Biol Med; 2018 Mar; 117():132-144. PubMed ID: 29309895
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice.
Lesné S; Docagne F; Gabriel C; Liot G; Lahiri DK; Buée L; Plawinski L; Delacourte A; MacKenzie ET; Buisson A; Vivien D
J Biol Chem; 2003 May; 278(20):18408-18. PubMed ID: 12626500
[TBL] [Abstract][Full Text] [Related]
25. Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.
Li Y; Chang L; Song Y; Gao X; Roselli F; Liu J; Zhou W; Fang Y; Ling W; Li H; Almeida OF; Wu Y
J Alzheimers Dis; 2016 Aug; 54(1):135-48. PubMed ID: 27497478
[TBL] [Abstract][Full Text] [Related]
26. Amyloid-β Oligomers Interact with Neurexin and Diminish Neurexin-mediated Excitatory Presynaptic Organization.
Naito Y; Tanabe Y; Lee AK; Hamel E; Takahashi H
Sci Rep; 2017 Feb; 7():42548. PubMed ID: 28211900
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease.
Balducci C; Frasca A; Zotti M; La Vitola P; Mhillaj E; Grigoli E; Iacobellis M; Grandi F; Messa M; Colombo L; Molteni M; Trabace L; Rossetti C; Salmona M; Forloni G
Brain Behav Immun; 2017 Feb; 60():188-197. PubMed ID: 27751869
[TBL] [Abstract][Full Text] [Related]
28. Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer's Disease Model Mice.
Taniguchi K; Yamamoto F; Arai T; Yang J; Sakai Y; Itoh M; Mamada N; Sekiguchi M; Yamada D; Saitoh A; Kametani F; Tamaoka A; Araki YM; Wada K; Mizusawa H; Araki W
J Alzheimers Dis; 2019; 70(3):937-952. PubMed ID: 31227651
[TBL] [Abstract][Full Text] [Related]
29. SorCS1 inhibits amyloid-β binding to neurexin and rescues amyloid-β-induced synaptic pathology.
Lee AK; Yi N; Khaled H; Feller B; Takahashi H
Life Sci Alliance; 2023 Apr; 6(4):. PubMed ID: 36697254
[TBL] [Abstract][Full Text] [Related]
30. Astrocytes and the TGF-β1 Pathway in the Healthy and Diseased Brain: a Double-Edged Sword.
Diniz LP; Matias I; Siqueira M; Stipursky J; Gomes FCA
Mol Neurobiol; 2019 Jul; 56(7):4653-4679. PubMed ID: 30377983
[TBL] [Abstract][Full Text] [Related]
31. Astrocytic N-Methyl-D-Aspartate Receptors Protect the Hippocampal Neurons Against Amyloid-β142-Induced Synaptotoxicity by Regulating Nerve Growth Factor.
Song Y; Du Z; Chen X; Zhang W; Zhang G; Li H; Chang L; Wu Y
J Alzheimers Dis; 2022; 85(1):167-178. PubMed ID: 34776441
[TBL] [Abstract][Full Text] [Related]
32. Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer's disease.
Taniguchi K; Yamamoto F; Amano A; Tamaoka A; Sanjo N; Yokota T; Kametani F; Araki W
Neurosci Res; 2022 Jul; 180():90-98. PubMed ID: 35257837
[TBL] [Abstract][Full Text] [Related]
33. The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.
Batista AF; Forny-Germano L; Clarke JR; Lyra E Silva NM; Brito-Moreira J; Boehnke SE; Winterborn A; Coe BC; Lablans A; Vital JF; Marques SA; Martinez AM; Gralle M; Holscher C; Klein WL; Houzel JC; Ferreira ST; Munoz DP; De Felice FG
J Pathol; 2018 May; 245(1):85-100. PubMed ID: 29435980
[TBL] [Abstract][Full Text] [Related]
34. Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice.
Ledo JH; Azevedo EP; Beckman D; Ribeiro FC; Santos LE; Razolli DS; Kincheski GC; Melo HM; Bellio M; Teixeira AL; Velloso LA; Foguel D; De Felice FG; Ferreira ST
J Neurosci; 2016 Nov; 36(48):12106-12116. PubMed ID: 27903721
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-β peptide oligomers.
Nunes-Tavares N; Santos LE; Stutz B; Brito-Moreira J; Klein WL; Ferreira ST; de Mello FG
J Biol Chem; 2012 Jun; 287(23):19377-85. PubMed ID: 22505713
[TBL] [Abstract][Full Text] [Related]
36. TRPA1 channels promote astrocytic Ca
Bosson A; Paumier A; Boisseau S; Jacquier-Sarlin M; Buisson A; Albrieux M
Mol Neurodegener; 2017 Jul; 12(1):53. PubMed ID: 28683776
[TBL] [Abstract][Full Text] [Related]
37. Transforming Growth Factor Beta Type I Role in Neurodegeneration: Implications for Alzheimer´s Disease.
Estrada LD; Oliveira-Cruz L; Cabrera D
Curr Protein Pept Sci; 2018; 19(12):1180-1188. PubMed ID: 29189146
[TBL] [Abstract][Full Text] [Related]
38. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
Izzo NJ; Xu J; Zeng C; Kirk MJ; Mozzoni K; Silky C; Rehak C; Yurko R; Look G; Rishton G; Safferstein H; Cruchaga C; Goate A; Cahill MA; Arancio O; Mach RH; Craven R; Head E; LeVine H; Spires-Jones TL; Catalano SM
PLoS One; 2014; 9(11):e111899. PubMed ID: 25390692
[TBL] [Abstract][Full Text] [Related]
39. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.
Shankar GM; Bloodgood BL; Townsend M; Walsh DM; Selkoe DJ; Sabatini BL
J Neurosci; 2007 Mar; 27(11):2866-75. PubMed ID: 17360908
[TBL] [Abstract][Full Text] [Related]
40. Glutamate activates GFAP gene promoter from cultured astrocytes through TGF-beta1 pathways.
Romão LF; Sousa Vde O; Neto VM; Gomes FC
J Neurochem; 2008 Jul; 106(2):746-56. PubMed ID: 18419760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
